The use of conventional insulin pump therapy and continuous glucose monitoring improves glycemic outcomes and diabetes-related psychosocial outcomes compared with traditional multiple daily insulin injections and capillary glucose monitoring (2-4). The gene discussed is INS; the disease is diabetes mellitus.